各国のワクチン接種状況 問題噴出: ずくなしの冷や水

2021年01月21日

各国のワクチン接種状況 問題噴出



※ You@You3_JP氏の2021/1/13のツイート
イスラエルの23才の若者は、コロナに感染後、回復し、コロナの抗体を持っているのに無謀にも不要なワクチンを接種してしまった。その結果、高熱がでて嘔吐した後、心不全と腎不全の多臓器炎症症候群となった
「コロナから回復した者がワクチンを接種するべきでない。この詳細はWHOに報告した」 twitter.com/andrewbostom/s…

※ mko@trappedsoldier氏の2021/1/18のツイート
カリフォルニア健康省が、モデルナのワクチンに対するアレルギー副反応が予想より多く発生し、ワクチン接種を停止するよう要請している。

Shawna Khalafi@ShawnaKhalafiTV氏の2021/1/18のツイート
#BREAKING from @CAPublicHealth
: Vaccine providers have been recommended to pause the administration of a specific lot of the #Moderna #COVID19 vaccine due to possible allergic reactions that are under investigation.

RT2021/1/17
51 adverse reactions reported & 1 person hospitalized in Delhi as India begins world’s largest Covid-19 vaccination program
Dozens of health workers in Delhi who were the first in line to be inoculated against Covid-19 have experienced side effects from the jab, with one admitted to the ICU, as India begins its nationwide immunization drive.

At least 51 healthcare workers in India’s capital suffered minor adverse reactions after receiving the jab on Saturday. Health authorities said the most common side effects were dizziness and headache.
Several people reported tightness in the chest and were administered medical treatment, while one individual experienced a serious health emergency after suffering from headache, rashes, respiratory distress, and tachycardia after taking the vaccine. The patient was administered adrenaline and rushed to an intensive care unit, India Today reported, adding that his symptoms worsened for at least 30 minutes after being hospitalized. The case has been classified by health authorities as a serious instance of AEFI (adverse events following immunization). However, his vitals are now said to be stable.
India granted emergency approval to two variants of the Covid-19 vaccine earlier this month: Bharat Biotech's Covaxin, and Covishield, a jab based on the AstraZeneca/Oxford formula and manufactured by the Serum Institute of India. Both shots are being used in India’s capital.
In total, 4,319 health workers were vaccinated in Delhi on the first day of the immunization drive, although officials had hoped that more than 8,000 personnel would receive the jab.
India hopes to vaccinate more than one billion people, starting with 30 million doctors, nurses, and other frontline workers. The government says it plans to immunize 300 million people by August.
Prime Minister Narendra Modi has hailed the massive public health initiative as a clear demonstration of India’s “capability,” but his government has been accused of rushing approval for the two jabs.

SPUTNIK2021/1/15
リトアニア 医療関係者が新型コロナに大規模感染 ファイザー社のワクチン接種後に
リトアニアの首都ヴィリニュスの医療機関の医師ら79人にコロナウイルスの感染が確認された。同医師らはこれまでにファイザー社とバイオエヌテック社のワクチンの初回接種を受けていた。事態の原因について同機関感染症センター長のリギタ・ヤンチョレナ教授が発表した。

同教授は動画の中で、「このことはワクチンとは関係がないと言える。おそらく、彼らはワクチンの接種の際にはすでに感染していた。登録のためのワクチンの審査を精査すると、ワクチンの初回接種後わずか12日後でリスクが20%下がっていることが明らかになっている」と指摘する。

nytimes Jan. 12, 2021
Doctor’s Death After Covid Vaccine Is Being Investigated

A Florida physician developed an unusual blood disorder shortly after he received the Pfizer vaccine. It is not yet known if the shot is linked to the illness.
Health authorities are investigating the case of a Florida doctor who died from an unusually severe blood disorder 16 days after receiving the Pfizer coronavirus vaccine.

Dr. Gregory Michael, a 56-year-old obstetrician and gynecologist in Miami Beach, received the vaccine at Mount Sinai Medical Center on Dec. 18 and died 16 days later from a brain hemorrhage, his wife, Heidi Neckelmann, wrote in a Facebook post.
マイアミビーチに住む56歳の産婦人科医グレゴリー・マイケル医師は、12月18日にマウントサイナイ医療センターでワクチンを受け、16日後に脳出血で死亡したと、妻のハイジ・ネッケルマン氏はフェイスブックの投稿に書いている。

Shortly after receiving the vaccine, Dr. Michael developed an extremely serious form of a condition known as acute immune thrombocytopenia, which prevented his blood from clotting properly.
In a statement, Pfizer, the maker of the vaccine, said it was “actively investigating” the case, “but we don’t believe at this time that there is any direct connection to the vaccine.”
“There have been no related safety signals identified in our clinical trials, the post-marketing experience thus far,” or with the technology used to make the vaccine, the company said. “Our immediate thoughts are with the bereaved family.”
https://ourworldindata.org/grapher/cumulative-covid-vaccinations?tab=chart&stackMode=absolute&country=RUS~ISR~GBR~USA~FRA~DEU~CAN~ITA~SWE®ion=World



Occhio David@DavidOcchio氏の2021/1/11のツイート
返信先: @segal_eranさん, @philippefroguelさん
I really hope for you (and for us) that it will work !
Your country will be the first to show if this strategy and this vaccine work.

But why still 42% of >60 y still in critical case, if 80% are vaccinated ?

Allen Berman@berman_allen氏の2021/1/11のツイート
Easy answer, it takes a couple of weeks to build immunity, and presumably, very few yet have gotten the booster. Have to wait a while longer, to see the vaccine kick in, "statistically".



RT2021/1/14
After months of bashing Russia’s Sputnik V vaccine, Western journalists in Moscow line up to be inoculated against Covid-19
Since Russian President Vladimir Putin announced the registration of Sputnik V, the world's first vaccine against Covid-19, sections of the Western media have taken aim at a formula they’ve dubbed both dangerous and ineffective.

However, in recent weeks, Moscow-based representatives of the very same outlets have lined up to receive the much-maligned Sputnik V. Living in Russia, it is no surprise that the correspondents have a much more realistic view of the country than their New York and London-based superiors.

On Friday, the New York Times’ Andrew Kramer revealed he had received his first dose of Sputnik V, praising the “bona fide accomplishment for Russian scientists continuing a long and storied practice of vaccine development,” even noting that Moscow has avoided some of the logistical problems seen in the West.

However, Kramer appears to have forgotten how his own newspaper was quick to bash the Russian formula, running a headline calling its faster-than-normal development “beyond stupid.” Of course, the breakneck speed applies to all available Covid-19 vaccines, which usually take years to be approved.

“Western experts focused mostly on the questionable early approval, not the vaccine’s design, which is similar to the one produced by Oxford University and AstraZeneca,” he noted.
The publication’s Moscow bureau chief, Anton Troianovski, also admitted to receiving the vaccine.

RT2021/1/16
13 Israelis suffer FACIAL PARALYSIS after taking Pfizer Covid jab, amid influx of reports detailing adverse effects
At least 13 Israelis have experienced facial paralysis after being administered the Pfizer Covid-19 vaccine, a month after the US Food and Drug Administration reported similar issues but said they weren’t linked to the jab.

Israel has been hailed for its speedy and efficient mass inoculation program, which has vaccinated a staggering 20 percent of the country’s population since the drive began at the end of December.

For a handful of Israelis, however, the initiative has led to some unexpected health scares. At least 13 people have reported mild facial paralysis after receiving the Pfizer/BioNTech jab, Israeli outlet Ynet reported, citing the Health Ministry, adding that officials believe the number of such cases could be higher.

“For at least 28 hours I walked around with it [facial paralysis],” one person who had the side effect told Ynet. “I can't say it was completely gone afterwards, but other than that I had no other pains, except a minor pain where the injection was, but there was nothing beyond that.”

The unnamed individual noted, though, that the unpleasant reaction was “something rare” and stressed that it was “important” people get vaccinated. However, he conceded that he was undecided about receiving a second dose of the vaccine.

Israel’s Health Ministry has stated that it is safe to administer the second shot, provided the facial paralysis passes and there are no lingering, long-term effects from the first jab. But some Israeli medical experts have chosen to ignore this advisory.

Ynet quoted Prof. Galia Rahav, director of the Infectious Diseases Unit at Sheba Medical Center, who said she did not feel “comfortable” with administering the second dose to someone who had received the first jab and subsequently suffered from paralysis.

“No one knows if this is connected to the vaccine or not. That's why I would refrain from giving a second dose to someone who suffered from paralysis after the first dose,” she told the outlet.

Last month the FDA disclosed that Bell’s palsy, a form of temporary facial paralysis, was reported by four participants during phase three trials of the Pfizer vaccine. All four cases involved individuals who had been given the actual jab. There were no reports of paralysis among the control group that received a placebo.

In its report, the FDA noted the “numerical imbalance” of Bell’s palsy cases among the vaccine and placebo groups, but it said there were no other “non-serious adverse events” that showed a similar pattern.

Ultimately, the US drug regulator concluded that the issue was “consistent with the expected background rate in the general population,” and added that there was no clear evidence linking the coronavirus vaccine to the unpleasant medical condition. Still, the agency recommended“surveillance for cases of Bell’s palsy with deployment of the vaccine into larger populations.”
posted by ZUKUNASHI at 20:26| Comment(0) | Covid19
この記事へのコメント
コメントを書く
お名前: [必須入力]

メールアドレス: [必須入力]

ホームページアドレス:

コメント: [必須入力]

※ブログオーナーが承認したコメントのみ表示されます。